Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
8
×
national blog main
biotech
boston blog main
boston top stories
clinical trials
national top stories
san francisco blog main
boston
fda
startups
deals
investing
ipo
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
detroit blog main
detroit top stories
glaxosmithkline
indiana blog main
indiana top stories
loxo oncology
medical device
messenger rna
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
sr one
texas blog main
texas top stories
vc
What
new
8
×
therapeutics
8
×
biotech
ipo
million
cancer
drug
medicines
raised
clinic
companies
developing
phase
positive
public
research
step
targets
years
address
adds
ago
aims
aldeyra
allogene
allosteric
approach
athena
based
bio
biotechs
black
called
ceo
chief
closer
club
company
continued
countouriotis
Language
unset
Current search:
new
×
" life sciences "
×
therapeutics
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M